Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features

Background Infiltrating B and T cells have been observed in several tumor tissues, including pancreatic ductal adenocarcinoma (PDAC). The majority known PDAC risk factors point to a chronic inflammatory process leading to different forms of immunological infiltration. Understanding pancreatic tumor infiltration may lead to improved knowledge of this devastating disease. Methods We extracted the immunoglobulins (IGs) and T cell receptors (TCRs) from RNA-sequencing of 144 PDAC from TCGA and 180 pancreatic normal tissue from GTEx. We used Shannon entropy to find differences in IG/TCR diversity. We performed a clonotype analysis considering the IG clone definition (same V and J segments, same CDR3 length, and 90% nucleotide identity between CDR3s) to study differences among the tumor samples. Finally, we performed an association analysis to find host and tumor factors associated with the IG/TCR. Results PDAC presented a richer and more diverse IG and TCR infiltration than normal pancreatic tissue. A higher IG infiltration was present in heavy smokers and females and it was associated with better overall survival. In addition, specific IG clonotypes classified samples with better prognosis explaining 24% of the prognosis phenotypic variance. On the other hand, a larger TCR infiltration was present in patients with previous history of diabetes and was associated with lower nonantigen load. Conclusions Our findings support PDAC subtyping according to its immune repertoire landscape with a potential impact on the understanding of the inflammatory basis of PDAC risk factors as well as the design of treatment options and prognosis monitoring.

[1]  D. Berman,et al.  Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ M2 macrophages, B cells and PD-L1 immune checkpoint , 2021, bioRxiv.

[2]  Kim-Anh Lê Cao,et al.  Variable selection in microbiome compositional data analysis , 2020, NAR genomics and bioinformatics.

[3]  N. Malats,et al.  Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose–Response Relationships , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[4]  O. Britanova,et al.  B cells, plasma cells and antibody repertoires in the tumour microenvironment , 2020, Nature Reviews Immunology.

[5]  Jinming Yu,et al.  Smoking history influences the prognostic value of peripheral naïve CD4+ T cells in advanced non-small cell lung cancer , 2019, Cancer Cell International.

[6]  A. Largeot,et al.  The B-Side of Cancer Immunity: The Underrated Tune , 2019, Cells.

[7]  S. Pineda,et al.  Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing , 2019, Nature Communications.

[8]  Brian Ruffell,et al.  Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.

[9]  S. Tomita,et al.  Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer , 2019, Journal of Translational Medicine.

[10]  Zheming Lu,et al.  T cell receptor β‐chain repertoire analysis of tumor‐infiltrating lymphocytes in pancreatic cancer , 2018, Cancer science.

[11]  Jie Lin,et al.  Network‐based integration of mRNA and miRNA profiles reveals new target genes involved in pancreatic cancer , 2018, Molecular carcinogenesis.

[12]  B. Nelson,et al.  Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer , 2018, Clinical Cancer Research.

[13]  E. Jaffee,et al.  T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma. , 2018, JCI insight.

[14]  Jérôme Galon,et al.  Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment , 2018, Front. Immunol..

[15]  S. Byers,et al.  Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular Mechanisms , 2018, Clinical Cancer Research.

[16]  N. Malats,et al.  Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives. , 2018, International journal of epidemiology.

[17]  Steven J. M. Jones,et al.  The Immune Landscape of Cancer , 2018, Immunity.

[18]  Neus Martínez-Bosch,et al.  Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy , 2018, Cancers.

[19]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. , 2017, Cancer cell.

[20]  E. Amir,et al.  HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer , 2018, British Journal of Cancer.

[21]  A. Butte,et al.  xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, bioRxiv.

[22]  K. Jirström,et al.  Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma. , 2016, Journal of gastrointestinal oncology.

[23]  A. Maitra,et al.  Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma , 2016, Scientific Reports.

[24]  K. Jirström,et al.  Prognostic impact of tumour‐infiltrating B cells and plasma cells in colorectal cancer , 2016, International journal of cancer.

[25]  K. Jirström,et al.  Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer , 2016, Journal of Ovarian Research.

[26]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[27]  N. Malats,et al.  Reduced risk of pancreatic cancer associated with asthma and nasal allergies , 2015, Gut.

[28]  Z. Cai,et al.  Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Sequencing of T Cell Receptors , 2015, Scientific Reports.

[29]  G. Kempermann Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[30]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[31]  Mikhail Shugay,et al.  MiXCR: software for comprehensive adaptive immunity profiling , 2015, Nature Methods.

[32]  M. Porta Faculty Opinions recommendation of Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. , 2015 .

[33]  J. Kench,et al.  Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.

[34]  P. Maisonneuve,et al.  Risk factors for pancreatic cancer: a summary review of meta-analytical studies. , 2015, International journal of epidemiology.

[35]  A. Miller,et al.  Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  G. de los Campos,et al.  Genome-Wide Regression and Prediction with the BGLR Statistical Package , 2014, Genetics.

[37]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[38]  J. Nielsen,et al.  Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. , 2014, Molecular & cellular proteomics : MCP.

[39]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[40]  C. Dinney,et al.  Inhibition of Inducible Heat Shock Protein-70 (Hsp72) Enhances Bortezomib-Induced Cell Death in Human Bladder Cancer Cells , 2013, PloS one.

[41]  L. Holmberg,et al.  The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. , 2013, Cancer letters.

[42]  R. Rance,et al.  Network properties derived from deep sequencing of human B-cell receptor repertoires delineate B-cell populations , 2013, Genome research.

[43]  Y. Kanai,et al.  Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer , 2013, British Journal of Cancer.

[44]  Jonathan B. Mitchem,et al.  Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. , 2013, Cancer research.

[45]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[46]  T. Whiteside,et al.  For Breast Cancer Prognosis, Immunoglobulin Kappa Chain Surfaces to the Top , 2012, Clinical Cancer Research.

[47]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[48]  G. Wahba An introduction to reproducing kernel hilbert spaces and why they are so useful , 2003 .

[49]  Shigeki Sugano,et al.  IFAC Proceedings Volumes (IFAC-PapersOnline) , 2010 .